Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 3 40-3, 1999, Pages

  Chen, Xian Ming ^a   Gores, Gregory J ^a   Paya, Carlos V ^b   LaRusso, Nicholas F ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Caspase; Cholangiopathies; Opportunistic infections; Parasitic diseases

Indexed keywords

CASPASE; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; APOPTOSIS; ARTICLE; BILIARY TRACT INFECTION; CHOLANGITIS; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOTOXICITY; DISEASE MODEL; EPITHELIUM; HUMAN; HUMAN CELL; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0032883236     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.3.g599     Document Type: Article

References (61)

1. Badley, A. D., J. A. McElhinny, P. J. Leibson, D. H. Lynch, M. R. Alderson, and C. V. Paya. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70: 199-206, 1996.
2. Benhamou, T., E. Caumes, Y. Gerosa, J. F. Cadranel, E. Dohin, C. Katlama, P. Amouyal, J. M. Canard, N. Azar, and C. Hoang. AIDS-related cholangiopathy: critical analysis of a prospective series of 26 patients. Dig. Dis. Sci. 38: 1113-1118, 1993.
3. Boonstra, J. G., F. J. van der Woude, P. C. Wever, J. C. Laterveer, M. R. Daha, and C. van Kooten. Expression and function of Fas (CD95) on human renal tubular epithelial cells. J. Am. Soc. Nephrol. 8: 1517-1524, 1997.
4. Buraud, M., E. Forget, L. Favennec, J. Bizet, J.-G. Gobert, and A.-M. Deluol. Sexual stage development of Cryptosporidia in the Caco-2 cell line. Infect. Immun. 59: 4610-4613, 1991.
5. Cello, J. P. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am. J. Med. 86: 539-546, 1989.
6. Chen, X.-M., S. A. Levine, P. Tietz, E. Krueger, M. A. McNiven, D. M. Jefferson, M. Mahle, and N. F. LaRusso. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 28: 906-913, 1998.
7. Dockrell, D. H., A. D. Badley, J. S. Villacian, C. J. Heppelmann, A. Algeciras, S. Ziesmer, H. Yagita, D. H. Lynch, P. C. Roche, P. J. Leibson, and C. V. Paya. The expression of Fas ligand by macrophages and its upregulation by human immuno-deficiency virus infection. J. Clin. Invest. 101: 2394-2405, 1998.
8. Estaquier, J., M. Marguerite, F. Sahuc, N. Bessis, C. Auriault, and J.-C. Amesisen. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mannsoni parasite infection. Eur. Cytokine Netw. 8: 153-160, 1997.
9. Faubion, W. A., M. E. Guicciardi, H. Miyoshi, S. F. Bronk, P. J. Roberts, P. A. Svingen, S. H. Kaufmann, and G. J. Gores. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 103: 137-145, 1999.
10. Flanigan, T. P., and R. Soave. Cryptosporidiosis. Prog. Clin. Parasitol. 3: 1-20, 1993.
11. Forbes, A., C. Blanshard, and B. Gazzard. Natural history of AIDS-related sclerosing cholangitis: a study of 20 cases. Gut 34: 116-121, 1993.
12. Galle, P. R., and P. H. Krammer. CD95-induced apoptosis in human liver disease. Semin. Liver Dis. 18: 141-151, 1998.
13. Gochuico, B. R., K. M. Miranda, E. M. Hessel, J. J. de Bie, A. J. van Oosterhout, W. W. Cruikshank, and A. Fine. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am. J. Physiol. 274 (Lung Cell. Mol. Physiol. 18): L444-L449, 1998.
14. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995.
15. Grubman, S.A., R. D. Perrone, D. W. Lee, S. L. Murray, L. C. Rogers, L. I. Wolkoff, A. E. Mulberg, V. Cherington, and D. M. Jefferson. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G1060-G1070, 1994.
16. Hiramatsu, N., N. Hayashi, K. Katayama, K. Mochizuki, Y. Kawanishi, A. Kasahara, H. Fusamoto, and T. Kamada. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19: 1354-1359, 1994.
17. Houghton, J. A., F. G. Harwood, and D. M. Tillman. Thymineless death in colon carcinoma cells is mediated via Fas signaling. Proc. Nad. Acad. Sci. USA 94: 8144-8149, 1997.
18. Inoue, Y., M. Yasukawa, and S. Fujita. Induction of T-cell apoptosis by human herpesvirus 6. J. Virol. 71: 3751-3759, 1997.
19. Ito, Y., T. Takeda, K. Umeshita, M. Sakon, K. Wakasa, N. Matsuura, and M. Monden. Fas antigen expression in hepatocellular carcinoma tissues. Oncol. Res. 5: 41-44, 1998.
20. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991.
21. Jones, B., P. J. Roberts, W. A. Faubion, E. Kominami, and G. J. Gores. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am. J. Physiol. 275 (Gastrointest. Liver Physiol. 38): G723-G730, 1998.
22. + killer cells in a small subset, leading to induction of apoptosis in bystander cells. Int. Immunol. 9: 1453-1462, 1997.
23. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182: 1777-1783, 1995.
24. Khan, I. A., T. Matsuura, and L. H. Kasper. Activation-mediated CD4-T cell unresponsiveness during acute Toxoplasma gondii infection in mice. Int. Immunol. 8: 887-896, 1996.
25. Kuroki, T., S. Seki, N. Kawakita, K. Nakatani, T. Hisa, T. Kitada, and H. Sakaguchi. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch. 429: 119-129, 1996.
26. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184: 429-440, 1996.
27. Lopes, M. F., V. F. da Veiga, A. R. Santos, M. E. Fonseca, and G. A. DosReis. Activation-induced CD4-T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154: 744-752, 1995.
28. Lopez-Velez, R., R. Tarazona, A. G. Camacho, E. Gomez-Mampaso, A. Guerrero, V. Moreira, and R. Villanueva. Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur. J. Clin. Microbiol. Infect. Dis. 14: 677-681, 1995.
29. Martinez-Lorenzo, M. J., M. A. Alava, A. Anel, A. Pineiro, and J. Naval. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89: 511-517, 1996.
30. McDonald, V., R. Stables, D. C. Warhurst, M. R. Barer, D. A. Blewett, H. D. Chapman, G. M. Connolly, P. O. Chiodini, and K. P. W. J. McAdam. In vitro cultivation of Cryptospordium parvum and screening for anticryptosporidial drugs. Antimicrob. Agents Chemother. 34: 1498-1500, 1990.
31. Medvedev, A. E., A. C. Johnsen, J. Haux, B. Steinkjer, K. Egeberg, D. H. Lynch, A. Sundan, and T. Espevik. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 9: 394-404, 1997.
32. Moller, P., H. Walczak, S. Reidl, J. Strater, and P. H. Krammer. Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia. Am. J. Pathol. 149: 9-13, 1996.
33. Mollereau, B., M. Deckert, O. Deas, F. Rieux-Laucat, F. Hirsch, A. Bernard, A. Fisher, D. H. Charpentier, D. F. Le, and A. Senik. CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation. J. Immunol. 156: 3184-3190, 1996.
34. Montel, A. H., M. R. Bochan, J. A. Hobbs, D. H. Lynch, and Z. Brahmi. Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 166: 236-246, 1995.
35. Nagata, S. Apoptosis by death factor. Cell 88: 355-365, 1997.
36. Nagata, S., and P. Golstein. The Fas death factor. Science 267: 1449-1456, 1995.
37. O'Donoghue, P. J. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25: 139-195, 1995.
38. Orlinick, J. R., K. B. Elkon, and M. V. Chao. Separate domains of the human Fas ligand dictate self-association and receptor binding. J. Biol. Chem. 272: 32221-32229, 1997.
39. Orlinick, J. R., A. Vaishnaw, K. B. Elkon, and M. V. Chao. Requirement of cysteine-rich repeats of the Fas receptor for binding by Fas ligand. J. Biol. Chem. 272: 28889-28894, 1997.
40. Oyaizu, N., N. Kayagaki, H. Yagita, S. Pahwa, and Y. Ikawa. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells. Biochem. Biophys. Res. Commun. 238: 670-675, 1997.
41. Pang, H., K. Miranda, and A. Fine. Sp3 regulates Fas expression in lung epithelial cells. Biochem. J. 333: 209-213, 1998.
42. Patel, T., S. Bronk, and G. J. Gores. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J. Clin. Invest. 94: 2183-2192, 1994.
43. Que, F. G., G. J. Gores, and N. F. LaRusso. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G106-G115, 1997.
44. Quirk, S. M., R. G. Cowan, and S. H. Huber. Fas antigen-mediated apoptosis of ovarian surface epithelial cells. Endocrinology 138: 4558-4566, 1997.
45. Ragland, B. D., L. S. Ashley, D. L. Vaux, and W. A. Petri. Entamoeba histolytica: target cells killed by trophozoites undergo DNA fragmentation which is not blocked by Bcl-2. Exp. Parasitol. 79: 460-467, 1994.
46. Rochelle, P. A., D. M. Ferguson, T. J. Handojo, R. de Leon, M. H. Stewart, and R. L. Wolfe. An assay combining cell culture with reverse transcriptase PCR to detect and determine the infectivity of waterborne Cryptosporidium parvum. Appl. Environ. Microbiol. 63: 2029-2037, 1997.
47. Rudi, J., D. Kuck, S. Strand, A. von Herbay, S. M. Mariani, P. H. Krammer, P. R. Galle, and W. Stremmel. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Invest. 102: 1506-1514, 1998.
48. Schelling, J. R., N. Nkemere, J. B. Kopp, and R. P. Cleveland. Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab. Invest. 78: 813-824, 1998.
49. Schneider, P., N. Holler, J. L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187: 1205-1213, 1998.
50. Smith, C. A., T. Farrah, and R. G. Goodwin. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962, 1994.
51. Strand, S., W. J. Hofmann, A. Grambihler, H. Hug, M. Volkmann, G. Otto, H. Wesch, S. M. Mariani, V. Hack, W. Stremmel, P. H. Krammer, and P. R. Galle. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat. Med. 4: 588-593, 1998.
52. Strater, J., I. Wellisch, S. Riedl, W. Henning, K. Koretz, A. Tandara, P. H. Krammer, and P. Moller. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113: 160-167, 1997.
53. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. Downregulation of Fas ligand by shedding. Nat. Med. 4: 31-36, 1998.
54. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. H. Drummond, and S. Nagata. Fas ligand in human serum. Nat. Med. 2: 317-322, 1996.
55. Tanaka, M., T. Suda, T. Yatomi, N. Nakamura, and S. Nagata. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J. Immunol. 158: 2303-2309, 1997.
56. Vakil, N. B., S. M. Schwartz, B. P. Buggy, C. F. Brummitt, M. Kherellah, D. M. Letzer, I. H. Gilson, and P. G. Jones. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N. Engl. J. Med. 334: 19-23, 1996.
57. Wang, S.-D., K.-J. Huang, Y.-S. Lin, and H.-Y. Lei. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152: 5014-5021, 1994.
58. Watson, R. W. G., H. P. Redmond, J. H. Wang, C. Condron, and D. Bouchier-Hayes. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J. Immunol. 156: 3986-3992, 1996.
59. Wilcox, C. M., and K. E. Monkemuller. Hepatobiliary diseases in patients with AIDS: focus on AIDS cholangiopathy and gall-bladder disease. Dig. Dis. 16: 205-213, 1998.
60. Yonehara, S., A. Ishii, and M. Yonehara. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756, 1989.
61. Zychlinsky, A., and P. Sansonetti. Apoptosis in bacterial pathogenesis. J. Clin. Invest. 100: 493-496, 1997.